Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients Grant uri icon

Overview

date/time interval

  • December 15, 2024 - April 30, 2026

sponsor award ID

  • 7 R33 HL158540-04

Affiliation